MACAU DAILY TIMES 澳門每日時報

Top Menu

  • Our Team
  • Editorial Statute
    • Code of Ethics
    • Privacy Policy
    • Terms and Conditions
  • Archive
    • PDF Editions
  • Contacts
  • Extra Times
    • Drive In
    • Book It
    • tTunes
    • Features
    • World of Bacchus
    • Taste of Edesia

Main Menu

  • Home
  • Macau
    • Photo Shop
    • Advertorial
  • Interview
  • Greater Bay
  • Business
    • Corporate Bits
  • China
  • Asia
  • World
  • Sports
  • Opinion
    • Editorial
    • Our Desk
    • Business Views
    • China Daily
    • Multipolar World
    • The Conversation
    • World Views
  • Our Team
  • Editorial Statute
    • Code of Ethics
    • Privacy Policy
    • Terms and Conditions
  • Archive
    • PDF Editions
  • Contacts
  • Extra Times
    • Drive In
    • Book It
    • tTunes
    • Features
    • World of Bacchus
    • Taste of Edesia
logo
FOUNDER & PUBLISHER Kowie Geldenhuys
EDITOR-IN-CHIEF Paulo Coutinho
Macau,

MACAU DAILY TIMES 澳門每日時報

  • Home
  • Macau
    • Photo Shop
    • Advertorial
  • Interview
  • Greater Bay
  • Business
    • Corporate Bits
  • China
  • Asia
  • World
  • Sports
  • Opinion
    • Editorial
    • Our Desk
    • Business Views
    • China Daily
    • Multipolar World
    • The Conversation
    • World Views
  • Craigie repeats success of qualification race and wins F4 World Cup

  • Alex Jiatong wins GBA GT Cup dethroning Han Lichao

  • FIA and AAMC confirm agreement extending GT World Cup in Macau through 2028

  • Al Dhaheri beats Colnaghi and qualifies on pole

  • Heinrich domination continues at Qualification Race

  • Urrutia wins Race 1 and keeps championship hopes alive

HeadlinesWorld
Home›Headlines›Breaking News | Pfizer confirms Covid pill’s results, potency versus omicron

Breaking News | Pfizer confirms Covid pill’s results, potency versus omicron

By -
Tuesday, December 14, 2021
155
0

This undated image provided by Pfizer in November 2021 shows the company’s COVID-19 pills

Pfizer said this evening (Tuesday) that its experimental pill to treat COVID-19 appears effective against the omicron variant.
The company also said full results of its 2,250-person study confirmed the pill’s promising early results against the virus: The drug reduced combined hospitalizations and deaths by about 89% among high-risk adults when taken shortly after initial COVID-19 symptoms.
Separate laboratory testing shows the drug retains its potency against the omicron variant, the company announced, as many experts had predicted. Pfizer tested the antiviral drug against a man-made version of a key protein that omicron uses to reproduce itself.
The updates come as COVID-19 cases, deaths and hospitalization are all rising again and the U.S. hovers around 800,000 pandemic deaths. The latest surge, driven by the delta variant, is accelerating due to colder weather and more indoor gatherings, even as health officials brace for the impact of the emerging omicron mutant.
The Food and Drug Administration is expected to soon rule on whether to authorize Pfizer’s pill and a competing pill from Merck, which was submitted to regulators several weeks earlier. If granted, the pills would be the first COVID-19 treatments that Americans could pickup at a pharmacy and take at home.
Pfizer’s data could help reassure regulators of its drug’s benefit after Merck disclosed smaller-than-expected benefits for its drug in final testing. Late last month, Merck said that its pill reduced hospitalizations and deaths by 30% in high-risk adults.
Both companies initially studied their drugs in unvaccinated adults who face the gravest risks from COVID-19, due to older age or health problems, such as asthma or obesity.
Pfizer is also studying its pill in lower-risk adults — including a subset who are vaccinated — but reported mixed data for that group on Tuesday.
In interim results, Pfizer said its drug failed to meet its main study goal: sustained relief from COVID-19 for four days during or after treatment, as reported by patients. But the drug did achieve a second goal by reducing hospitalizations by about 70% among that group, which included otherwise healthy unvaccinated adults and vaccinated adults with one or more health issues. Less than 1% of patients who got the drug were hospitalized, compared with 2.4% of patients who got a dummy pill.
An independent board of medical experts reviewed the data and recommended Pfizer continue the study to get the full results before proceeding further with regulators.
Across both of Pfizer’s studies, adults taking the company’s drug had a 10-fold decrease in virus levels compared with those on placebo.
The prospect of new pills to fight COVID-19 can’t come soon enough for communities in the Northeast and Midwest, where many hospitals are once again being overloaded by incoming virus cases.
Both the Merck and Pfizer pills are expected to perform well against omicron because they don’t target the coronavirus’ spike protein, which contains most of the new variant’s mutations.
Centers for Disease Control and Prevention Director Rochelle Walensky, appearing on NBC’s “Today” on Tuesday, said the best way for people to protect themselves against COVID-19 is to get vaccinated and get a booster shot. She said the Pfizer pill, if authorized by the FDA, “will be another great tool, but we need to diagnose people early.”
The U.S. government has agreed to purchase enough of Pfizer’s drug to treat 10 million people and enough of Merck’s to treat 3 million, pending FDA authorization.
MDT/AP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Print (Opens in new window) Print

Like this:

Like Loading…

Related

TagsCovid-19Pandemic
Previous Article

Financial Secretary rejects claims of Suncity bringing ...

Next Article

Wednesday, December 15, 2021 – edition no. ...

Related articles More from author

  • HeadlinesMacau

    Covid-19 transmission rises as gov’t steps up vaccinations at care homes

    Wednesday, July 1, 2026
    By Yuki Lei, MDT
  • HeadlinesWorld

    Virus puts world in intensive care; state of emergency

    Wednesday, April 8, 2020
    By -
  • Breaking NewsMacau

    New case of Covid-19 in Macau, tally at 46

    Friday, June 26, 2020
    By -
  • HeadlinesMacau

    Health Bureau stresses 11th case is not very contagious

    Tuesday, March 17, 2020
    By Daniel Beitler, MDT
  • Macau

    Pui Ching principal hopes daily RAT requirements end soon

    Thursday, February 2, 2023
    By -
  • China

    A new genetic analysis of animals may help find Covid-19’s origin

    Monday, September 23, 2024
    By -

  • Extra TimesTaste of Edesia

    Sniff and savor the ‘diamond of the kitchen’

  • Sports

    Ferrari wins the 24 Hours of Le Mans for third year in a row

  • Features

    In Macao. BY CHARLES A. GUNNISON

DAILY EDITION

Friday, November 20, 2026 – edition no. 5079
Friday, November 20, 2026 – edition no. 5079

Greater Bay

MDT MACAU GRAND PRIX SPECIAL

November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Oct    

Timeline

  • Sunday, November 22, 2026

    Craigie repeats success of qualification race and wins F4 World Cup

  • Sunday, November 22, 2026

    Alex Jiatong wins GBA GT Cup dethroning Han Lichao

  • Sunday, November 22, 2026

    FIA and AAMC confirm agreement extending GT World Cup in Macau through 2028

  • Saturday, November 21, 2026

    Al Dhaheri beats Colnaghi and qualifies on pole

  • Saturday, November 21, 2026

    Heinrich domination continues at Qualification Race

  • Saturday, November 21, 2026

    Urrutia wins Race 1 and keeps championship hopes alive

  • Saturday, November 21, 2026

    Kenzo Craigie wins drama-packed Qualification Race

  • Saturday, November 21, 2026

    Damon Chan wins interrupted race

  • Saturday, November 21, 2026

    Hickman shatters lap record for Motorcycle Grand Prix title

  • Friday, November 20, 2026

    China-Russia-US Heads of State Declaration toward Peace

Extra Times

Drive InExtra Times

‘Madden’ biopic can’t find a playbook to stick with

Which play to run is a question that can bedevil any football coach, and it’s also what dooms David O. Russell’s fumbled biopic “Madden.” “Madden” may sport an all-star cast ...
  • Juksunchae: A Study in Precision and Contemporary Korean Cuisine

    By Irene Sam, MDT
    Friday, November 20, 2026
  • Reframing the “Hundreds of Flavors”: Chiang and Ho at Zi Yat Heen

    By -
    Friday, November 20, 2026
  • Three chefs. One horizon. Six Michelin stars

    By Irene Sam, MDT
    Friday, November 13, 2026
  • James Gray delivers a milestone crime drama in ‘Paper Tiger’

    By MDT/AP
    Friday, November 13, 2026
  • Recent

  • Popular

  • Craigie repeats success of qualification race and wins F4 World Cup

    By Renato Marques, MDT
    Sunday, November 22, 2026
  • Alex Jiatong wins GBA GT Cup dethroning Han Lichao

    By Renato Marques, MDT
    Sunday, November 22, 2026
  • FIA and AAMC confirm agreement extending GT World Cup in Macau through 2028

    By Times Reporter
    Sunday, November 22, 2026
  • Al Dhaheri beats Colnaghi and qualifies on pole

    By Renato Marques, MDT
    Saturday, November 21, 2026
  • Heinrich domination continues at Qualification Race

    By Renato Marques, MDT
    Saturday, November 21, 2026
  • Urrutia wins Race 1 and keeps championship hopes alive

    By Renato Marques, MDT
    Saturday, November 21, 2026
  • Kenzo Craigie wins drama-packed Qualification Race

    By Renato Marques, MDT
    Saturday, November 21, 2026
  • Canidrome may have its days numbered, decision in ‘one or two months’

    By Paulo Coutinho, MDT
    Thursday, May 26, 2016
  • Animal Welfare | Macau: Anima slams Canidrome management for avoiding debate

    By -
    Wednesday, May 4, 2016
  • Editorial | Canidoomed

    By Paulo Coutinho, MDT
    Wednesday, June 1, 2016
  • Animal Welfare | Canidrome presented with ultimatum: close or move

    By Daniel Beitler, MDT
    Friday, July 22, 2016
  • Australia regulator cracks down on alleged exportation of dogs to Macau

    By Paulo Coutinho, MDT
    Friday, June 10, 2016
  • Animal rights | Canidrome: Anima in fresh airline negotiations as Canidrome closure looks more likely

    By Daniel Beitler, MDT
    Friday, May 27, 2016
  • USE OF ENGLISH IN MACAU | A ‘de facto’ official language

    By Catarina Pinto
    Monday, July 6, 2015
  • Contact our Administrator
  • Contact our Editor-in-Chief
  • Contacts
  • Our Team
  • Privacy Policy
  • Terms and Conditions
  • Editorial Statute
  • Code of Ethics
COPYRIGHT © MACAU DAILY TIMES 2008-2026. ALL RIGHTS RESERVED
MACAU DAILY TIMES
  • Home
  • Macau
    • Photo Shop
    • Advertorial
  • Interview
  • Greater Bay
  • Business
    • Corporate Bits
  • China
  • Asia
  • World
  • Sports
  • Opinion
    • Editorial
    • Our Desk
    • Business Views
    • China Daily
    • Multipolar World
    • The Conversation
    • World Views
  • Our Team
  • Editorial Statute
    • Code of Ethics
    • Privacy Policy
    • Terms and Conditions
  • Archive
    • PDF Editions
  • Contacts
  • Extra Times
    • Drive In
    • Book It
    • tTunes
    • Features
    • World of Bacchus
    • Taste of Edesia
Loading Comments...

You must be logged in to post a comment.

%d